Double maintains 2 strategies that include XENE - Xenon Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FLDR | -0.10% | $877.98M | 0.15% |
NYF | 0.19% | $880.31M | 0.25% |
STIP | 0.43% | $12.57B | 0.03% |
CLIP | 0.48% | $1.50B | 0.07% |
GOVT | -0.53% | $27.36B | 0.05% |
IBTP | 0.54% | $132.62M | 0.07% |
HYMB | -0.58% | $2.52B | 0.35% |
VRIG | 0.61% | $1.18B | 0.3% |
MMIT | 0.61% | $834.19M | 0.3% |
FLGV | -0.80% | $979.52M | 0.09% |
BSV | -0.83% | $38.07B | 0.03% |
FMB | -0.88% | $1.90B | 0.65% |
JPST | -0.88% | $31.04B | 0.18% |
SPTI | -0.93% | $8.81B | 0.03% |
SUB | -1.00% | $9.55B | 0.07% |
HYD | 1.01% | $3.30B | 0.32% |
UDN | -1.13% | $139.73M | 0.78% |
GOVI | 1.42% | $872.61M | 0.15% |
FLMI | 1.44% | $683.24M | 0.3% |
PULS | 1.48% | $11.30B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -20.83% | $37.82M | -99.94% | 0.00% |
VSTA | -12.24% | $326.42M | +15.63% | 0.00% |
CBOE | -11.21% | $23.79B | +30.06% | 1.07% |
CREG | -10.69% | $17.46M | -17.65% | 0.00% |
BGFV | -10.39% | $27.43M | -65.42% | 4.20% |
CME | -7.89% | $103.02B | +39.52% | 3.67% |
LITB | -7.46% | $24.46M | -56.54% | 0.00% |
K | -5.14% | $28.62B | +39.03% | 2.75% |
PRPO | -4.21% | $15.06M | +66.83% | 0.00% |
PRT | -4.11% | $49.15M | +4.94% | 11.06% |
VHC | -3.84% | $33.26M | +91.41% | 0.00% |
VSA | -3.76% | $6.89M | -41.29% | 0.00% |
IMNN | -3.65% | $34.91M | +36.30% | 0.00% |
MKTX | -3.25% | $8.03B | +8.29% | 1.40% |
MOGO | -2.65% | $35.24M | -7.69% | 0.00% |
COR | -1.49% | $56.34B | +31.81% | 0.74% |
HIHO | -1.14% | $7.80M | -17.59% | 3.95% |
CPSH | -0.94% | $44.45M | +76.88% | 0.00% |
HUSA | -0.83% | $7.53M | -63.36% | 0.00% |
NEOG | 0.09% | $1.35B | -52.92% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NEOG | 0.09% | $1.35B | -52.92% | 0.00% |
PULM | 0.19% | $29.95M | +345.65% | 0.00% |
CL | 0.21% | $74.80B | +1.51% | 2.18% |
BPT | 0.47% | $13.51M | -73.14% | 0.00% |
LTM | 0.81% | $11.38B | -96.47% | 2.69% |
HUSA | -0.83% | $7.53M | -63.36% | 0.00% |
ED | 0.89% | $37.25B | +11.82% | 3.26% |
CPSH | -0.94% | $44.45M | +76.88% | 0.00% |
HIHO | -1.14% | $7.80M | -17.59% | 3.95% |
MO | 1.29% | $100.19B | +30.90% | 6.79% |
PPC | 1.44% | $11.62B | +54.56% | 0.00% |
PRA | 1.47% | $1.18B | +59.22% | 0.00% |
COR | -1.49% | $56.34B | +31.81% | 0.74% |
BTCT | 1.49% | $22.13M | +59.26% | 0.00% |
ZCMD | 1.52% | $28.19M | -6.20% | 0.00% |
AGL | 1.75% | $923.11M | -64.26% | 0.00% |
MSIF | 1.76% | $734.58M | +55.89% | 6.87% |
OXBR | 1.84% | $13.10M | -18.89% | 0.00% |
VZ | 1.99% | $182.69B | +7.44% | 6.22% |
EXC | 2.01% | $44.12B | +18.98% | 3.56% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 64.93% | $4.60B | 0.35% |
IBB | 61.82% | $5.23B | 0.45% |
FBT | 59.30% | $1.03B | 0.56% |
XPH | 57.58% | $138.73M | 0.35% |
GNOM | 57.29% | $41.00M | 0.5% |
PINK | 56.77% | $130.02M | 0.5% |
PBE | 56.69% | $223.00M | 0.58% |
BBH | 54.44% | $330.20M | 0.35% |
PTH | 53.91% | $97.74M | 0.6% |
IWC | 52.42% | $784.70M | 0.6% |
VHT | 52.33% | $14.98B | 0.09% |
FHLC | 51.87% | $2.40B | 0.084% |
IWO | 51.15% | $11.24B | 0.24% |
ARKG | 51.14% | $927.51M | 0.75% |
VTWO | 50.58% | $12.05B | 0.07% |
IWM | 50.13% | $63.57B | 0.19% |
ISCG | 50.01% | $658.37M | 0.06% |
FXH | 49.96% | $907.30M | 0.62% |
XHE | 49.83% | $170.80M | 0.35% |
SCHA | 49.82% | $16.81B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -35.46% | $111.21M | 0.59% |
VIXY | -34.60% | $141.70M | 0.85% |
BTAL | -34.46% | $320.45M | 1.43% |
IVOL | -19.45% | $348.07M | 1.02% |
SHYM | -15.85% | $323.12M | 0.35% |
FTSD | -14.40% | $212.84M | 0.25% |
TPMN | -12.70% | $30.91M | 0.65% |
XONE | -11.57% | $616.52M | 0.03% |
ULST | -10.92% | $660.43M | 0.2% |
FXY | -10.52% | $858.65M | 0.4% |
SPTS | -10.24% | $5.74B | 0.03% |
TFLO | -9.99% | $7.03B | 0.15% |
STPZ | -9.64% | $453.91M | 0.2% |
CANE | -9.45% | $10.83M | 0.29% |
SMB | -9.42% | $269.90M | 0.07% |
BILZ | -8.23% | $843.92M | 0.14% |
CTA | -8.12% | $1.08B | 0.76% |
DFNM | -7.74% | $1.54B | 0.17% |
TBLL | -7.70% | $2.32B | 0.08% |
BIL | -7.60% | $44.37B | 0.1356% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDYA | 53.70% | $1.76B | -43.98% | 0.00% |
CRNX | 53.35% | $2.86B | -32.73% | 0.00% |
ATXS | 52.99% | $279.35M | -45.06% | 0.00% |
KYMR | 52.96% | $1.97B | -5.94% | 0.00% |
DNLI | 50.35% | $1.97B | -26.65% | 0.00% |
RVMD | 48.57% | $7.28B | +2.40% | 0.00% |
IMVT | 47.56% | $2.53B | -43.62% | 0.00% |
NRIX | 47.44% | $811.15M | -31.71% | 0.00% |
IONS | 46.95% | $5.33B | -8.45% | 0.00% |
OCUL | 46.58% | $1.30B | +40.34% | 0.00% |
XNCR | 46.49% | $550.51M | -67.62% | 0.00% |
BHVN | 46.48% | $1.51B | -58.16% | 0.00% |
QTRX | 46.27% | $203.27M | -67.92% | 0.00% |
VYGR | 46.17% | $156.05M | -65.36% | 0.00% |
SNDX | 45.72% | $913.82M | -44.95% | 0.00% |
RGNX | 45.71% | $449.94M | -37.49% | 0.00% |
CNNE | 45.40% | $1.18B | +3.34% | 2.55% |
IQV | 44.92% | $24.40B | -36.61% | 0.00% |
ROIV | 44.86% | $8.06B | +8.76% | 0.00% |
DHR | 44.80% | $136.31B | -24.64% | 0.59% |
Yahoo
VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company will present at the 2025 RBC Capital Markets Global Healthcare Conference taking place in New York, NY from May 20-21, 2025. Fireside Chat Presentation Details: Date: Wednesday, May 21, 2025 Time: 10:
Yahoo
We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other stocks. Wall Street’s main indices finished mixed on Tuesday, as investors digested the country’s latest inflation figures, which came out lower than […]
Yahoo
XENE incurs narrower-than-estimated first-quarter 2025 loss. Studies on lead candidate, azetukalner, in epilepsy and MDD are progressing well.
Yahoo
Xenon Pharmaceuticals Inc (XENE) reports robust cash reserves and advances in epilepsy and psychiatry studies, despite minor timeline adjustments.
SeekingAlpha
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2025 Earnings Conference Call May 12, 2025 4:30 AM ETCorporate ParticipantsChad Fugere - Vice President,...
Yahoo
BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. XENE) on Monday reported a loss of $65 million in its first quarter. On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 83 cents.
Current Value
$28.921 Year Return
Current Value
$28.921 Year Return